GNH USA

Europe — EMA

Olicard Retard (Isosorbide Mononitrate)

GNH USA supplies Olicard Retard (Isosorbide Mononitrate), a nitrate vasodilator for chronic stable and variant angina. Request a quote for global supply.

Request sourcing

1
Pack/s

What is Isosorbide Mononitrate?

Isosorbide Mononitrate, the active ingredient in Olicard Retard, is a nitrate vasodilator presented as a prolonged‑release oral tablet for once‑daily use in adults with chronic stable angina. It helps to prevent chest pain episodes by improving coronary blood flow.

GNH USA supplies Olicard Retard as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

What is Isosorbide Mononitrate used for?

Isosorbide Mononitrate is used in the management of angina‑related conditions, acting on the coronary circulation to reduce myocardial oxygen demand. - Chronic stable angina: reduces frequency of angina attacks and improves exercise tolerance. - Variant (Prinzmetal) angina: prevents episodic coronary spasm and associated chest pain. - Post‑myocardial infarction prophylaxis: helps lower risk of recurrent angina episodes during recovery.

What are the side effects of Isosorbide Mononitrate?

Adverse reactions may occur with any nitrate therapy.

Common Side Effects: - Headache: mild to moderate, often transient. - Flushing: warmth and redness of the skin, especially face. - Dizziness or light‑headedness, particularly on standing. - Nausea or upset stomach. - Palpitations: sensation of rapid or irregular heartbeat.

Serious or Rare Side Effects: - Severe hypotension: marked drop in blood pressure causing fainting. - Methemoglobinemia: abnormal hemoglobin that impairs oxygen delivery. - Allergic reactions: rash, itching, swelling, or difficulty breathing. - Syncope: sudden loss of consciousness unrelated to posture.

What precautions apply to Isosorbide Mononitrate?

Before initiating therapy, clinicians should evaluate cardiovascular status and concomitant medications. - Assess blood pressure: avoid use in patients with uncontrolled hypotension. - Review cardiac history: caution in recent myocardial infarction or severe heart failure. - Evaluate liver and renal function: dose may need adjustment in impairment. - Avoid concurrent use of phosphodiesterase‑5 inhibitors: risk of profound hypotension. - Counsel on orthostatic changes: rise slowly from sitting or lying positions. - Store at ambient temperature: keep below 25°C in the original container, protected from moisture.

What does Isosorbide Mononitrate interact with?

Isosorbide mononitrate interacts with several drug classes; careful monitoring is advised.

Major Interactions (Avoid): - Sildenafil, tadalafil, vardenafil: combined vasodilatory effect can cause severe hypotension. - Other nitrates (e.g., nitroglycerin): additive blood‑pressure lowering effect.

Moderate Interactions (Monitor Closely): - Antihypertensives (ACE inhibitors, ARBs, beta‑blockers): may enhance blood‑pressure reduction. - Diuretics: increase risk of electrolyte imbalance and hypotension. - Alcohol: can potentiate vasodilatory response and dizziness.

Frequently asked questions

What is Olicard Retard used for?+
Olicard Retard contains isosorbide mononitrate, a nitrate vasodilator indicated to prevent episodes of chest pain in adults with chronic stable angina, variant (Prinzmetal) angina, and to reduce recurrent angina after a myocardial infarction.
How does isosorbide mononitrate work?+
The drug is converted in the body to nitric oxide, which activates guanylate cyclase in vascular smooth‑muscle cells. This raises cyclic GMP levels, causing relaxation of arteries and veins, lowering cardiac preload and afterload, and decreasing the heart’s oxygen demand.
What is the usual dose of Olicard Retard?+
The prescribed dose of Olicard Retard is determined by the treating physician based on the patient’s clinical condition, response, and tolerance. Dosage adjustments are made individually and should follow the prescriber’s instructions.
Is Olicard Retard safe during pregnancy or breastfeeding?+
Safety data for isosorbide mononitrate in pregnancy are limited. It should only be used if the potential benefit justifies any potential risk to the fetus. Breastfeeding mothers should consult their healthcare provider, as the drug may be excreted in breast milk.
How do I order Olicard Retard from GNH USA?+
To place an order, submit an enquiry on the product page at gnh-usa.com specifying the required quantity. GNH USA works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.
How does Olicard Retard compare with other anti‑anginal drugs?+
Compared with short‑acting nitrates such as nitroglycerin, Olicard Retard offers a once‑daily, prolonged‑release formulation that provides more stable plasma concentrations and reduces the need for multiple daily dosing. It is also distinct from beta‑blockers, which lower heart rate, whereas nitrates primarily reduce preload.
How should Olicard Retard be stored and handled?+
Store tablets at ambient temperature, preferably below 25 °C, in the original blister pack or container. Protect them from moisture and direct sunlight to maintain stability throughout the shelf life.
How is Olicard Retard administered?+
Olicard Retard is taken orally, usually once daily with or without food, as directed by the prescribing clinician. Swallow the tablet whole; do not split, chew, or crush the extended‑release formulation.
What are the most serious risks associated with Olicard Retard?+
Serious adverse events include severe hypotension, syncope, and rare cases of methemoglobinemia. Patients should be monitored for sudden drops in blood pressure, fainting, or signs of oxygen‑delivery impairment and seek immediate medical attention if these occur.
Who should not use Olicard Retard?+
Olicard Retard is contraindicated in patients with known hypersensitivity to isosorbide mononitrate or other nitrates, those with severe hypotension, and individuals who have taken phosphodiesterase‑5 inhibitors within 24 hours due to the risk of dangerous blood‑pressure falls.
Information provided on this page is for educational use by procurement and clinical professionals. Always consult a licensed healthcare provider for medical advice and prescribing decisions. GNH USA supplies this product subject to applicable regulatory and licensing requirements.

Product details

Drug
Isosorbide Mononitrate
Route
Oral Use
Manufacturer
Viatris Healthcare Limited
Origin
EU

Related products